Elarcosa, Millet M.

HRN: 14-40-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
CEFUROXIME 500MG (TAB)
08/15/2023
08/22/2023
PO
500mg
BID
S/P NSVD WITH RMLE
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: